Education
About Us
Working with TipRanks
Follow Us
VentriPoint Diagnostics Ltd (TSE:VPT)
:VPT
VPT Stock Chart & Stats
C$0.14
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.14
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.20
Previous CloseN/A
Volume32.00K
Average Volume (3M)106.78K
Market Cap
C$23.48M
Enterprise ValueN/A
Total Cash (Recent Filing)C$68.32K
Total Debt (Recent Filing)C$2.35M
Price to Earnings (P/E)―
Beta-0.14
Next Earnings
May 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding167,704,010
10 Day Avg. Volume85,718
30 Day Avg. Volume106,775
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-5.31
Price to Sales (P/S)166.31
P/FCF Ratio-4.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VentriPoint Diagnostics News
VPT FAQ
What was VentriPoint Diagnostics Ltd’s price range in the past 12 months?
VentriPoint Diagnostics Ltd lowest stock price was C$0.07 and its highest was C$0.20 in the past 12 months.
What is VentriPoint Diagnostics Ltd’s market cap?
VentriPoint Diagnostics Ltd’s market cap is C$23.48M.
When is VentriPoint Diagnostics Ltd’s upcoming earnings report date?
VentriPoint Diagnostics Ltd’s upcoming earnings report date is May 05, 2026 which is in 133 days.
How were VentriPoint Diagnostics Ltd’s earnings last quarter?
VentriPoint Diagnostics Ltd released its earnings results on Nov 28, 2025. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is VentriPoint Diagnostics Ltd overvalued?
According to Wall Street analysts VentriPoint Diagnostics Ltd’s price is currently Overvalued.
Does VentriPoint Diagnostics Ltd pay dividends?
VentriPoint Diagnostics Ltd does not currently pay dividends.
What is VentriPoint Diagnostics Ltd’s EPS estimate?
VentriPoint Diagnostics Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VentriPoint Diagnostics Ltd have?
VentriPoint Diagnostics Ltd has 167,704,010 shares outstanding.
What happened to VentriPoint Diagnostics Ltd’s price movement after its last earnings report?
VentriPoint Diagnostics Ltd reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -11.111%.
Which hedge fund is a major shareholder of VentriPoint Diagnostics Ltd?
Currently, no hedge funds are holding shares in TSE:VPT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.
Technical Analysis
Aurora Spine
―
Perimeter Medical Imaging AI
―
Quipt Home Medical
―
Profound Medical
―
Theralase Technologies
―
Options Prices
Currently, No data available
---